Literature DB >> 7753253

Long-term survival of vascular accesses in a large chronic hemodialysis population.

J A Chazan1, M R London, L M Pono.   

Abstract

Complications associated with vascular accesses account for approximately 30% of hospital admissions for chronic hemodialysis patients. Long-term patency of access was evaluated in 76 patients, without diabetes mellitus, who had been on dialysis for at least 3 years and 41 patients, with diabetes mellitus, who had been on dialysis for over 2 years. Fistulas functioned longer than grafts (58 vs. 22 months, p < 0.01, in nondiabetics and 70 vs 22 months, p < 0.01, in patients with diabetes). Declotting or revision of restored graft function for short periods of time (< 6-10 months) and subsequent declotting was ineffective. Infections were uncommon in grafts (1 per 13.5 years of dialysis) and in fistulas (1 in 200 years of dialysis).

Entities:  

Mesh:

Year:  1995        PMID: 7753253     DOI: 10.1159/000188461

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  13 in total

Review 1.  Preserving function and long-term patency of dialysis access.

Authors:  J A Akoh; N S Hakim
Journal:  Ann R Coll Surg Engl       Date:  1999-09       Impact factor: 1.891

Review 2.  Dialysis Access Anatomy and Interventions: A Primer.

Authors:  Charles Martin; Rex Pillai
Journal:  Semin Intervent Radiol       Date:  2016-03       Impact factor: 1.513

3.  Arteriovenous fistulas among incident hemodialysis patients in Department of Defense and Veterans Affairs facilities.

Authors:  Frank P Hurst; Kevin C Abbott; Dominic Raj; Mahesh Krishnan; Carlos E Palant; Lawrence Y Agodoa; Rahul M Jindal
Journal:  J Am Soc Nephrol       Date:  2010-08-12       Impact factor: 10.121

4.  Declotting, maintenance, and avoiding procedural complications of native arteriovenous fistulae.

Authors:  George Zaleski
Journal:  Semin Intervent Radiol       Date:  2004-06       Impact factor: 1.513

5.  Percutaneous management of thrombosed dialysis access grafts.

Authors:  Thuong Van Ha
Journal:  Semin Intervent Radiol       Date:  2004-06       Impact factor: 1.513

Review 6.  Oral anticoagulant therapy in hemodialysis patients: do the benefits outweigh the risks?

Authors:  Guido Finazzi; Giulio Mingardi
Journal:  Intern Emerg Med       Date:  2009-07-16       Impact factor: 3.397

7.  Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using cefotaxime.

Authors:  Mojgan Mortazavi; Samira Alsaeidi; Roohollah Sobhani; Fereshte Salimi; Abdolamir Atapour; Nima Sharif; Mojtaba Akbari; Bahram Pakzad; Amir Hosein Davarpanah Jazi
Journal:  J Res Med Sci       Date:  2011-03       Impact factor: 1.852

8.  Percutaneous treatment of failed native dialysis fistulas: use of pulse-spray pharmacomechanical thrombolysis as the primary mode of therapy.

Authors:  Sung Ki Cho; Heon Han; Sam Soo Kim; Ji Yeon Lee; Sung Wook Shin; Young Soo Do; Kwang Bo Park; Sung Wook Choo; In-Wook Choo
Journal:  Korean J Radiol       Date:  2006 Jul-Sep       Impact factor: 3.500

9.  Midterm experience of ipsilateral axillary-axillary arteriovenous loop graft as tertiary access for haemodialysis.

Authors:  J P Hunter; M L Nicholson
Journal:  J Transplant       Date:  2014-03-23

Review 10.  Oral anticoagulant therapy in patients receiving haemodialysis: is it time to abandon it?

Authors:  Marek Saracyn; Dorota Brodowska-Kania; Stanisław Niemczyk
Journal:  ScientificWorldJournal       Date:  2013-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.